Advocacy intelligence hub — real-time data for patient organizations
Centre Hospitalier Universitaire de la Réunion — NA
Canadian Cancer Trials Group — PHASE3
Hackensack Meridian Health — NA
Aurion Biotech — PHASE3
Shanghai Miracogen Inc. — PHASE3
Hospital Israelita Albert Einstein — PHASE2
AugMend Health Inc. — NA
Opus Genetics, Inc — PHASE1, PHASE2
Gustave Roussy, Cancer Campus, Grand Paris — PHASE2
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Tomasz Masior
VectivBio AG
Lawrence A. Yannuzzi, MD, MD
Manhattan Eye, Ear & Throat Hospital
📍 NEW YORK, NY
Simran Singh
Sobi, Inc.
📍 Birmingham, Alabama
Brian P Brooks, M.D.
National Eye Institute (NEI)
📍 Bethesda, Maryland
Guillermo Garcia-Manero, M.D
M.D. Anderson Cancer Center
📍 HOUSTON, TX
Matthew B. Rettig, MD, MD
VA Greater Los Angeles Healthcare System, West Los Angeles, CA
📍 LOS ANGELES, CA